Michelle R Kaminski1, Anita Raspovic2, Lawrence P McMahon3, Giovanni F M Strippoli4, Suetonia C Palmer5, Marinella Ruospo6, Sarah Dallimore7, Karl B Landorf2. 1. Discipline of Podiatry, and Lower Extremity and Gait Studies Program, La Trobe University, Melbourne, Victoria 3086, Australia Department of Podiatry, Eastern Health, Melbourne, Victoria 3156, Australia. 2. Discipline of Podiatry, and Lower Extremity and Gait Studies Program, La Trobe University, Melbourne, Victoria 3086, Australia. 3. Department of Renal Medicine and Obstetric Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3128, Australia. 4. Diaverum Medical Scientific Office, Lund, Sweden School of Public Health, University of Sydney, Sydney, New South Wales, Australia University of Bari, Bari, Italy Amedeo Avogadro University of Eastern Piedmont, Novara, Italy Diaverum Academy, Bari, Italy. 5. Department of Medicine, University of Otago Christchurch, Christchurch 8140, New Zealand. 6. Diaverum Medical Scientific Office, Lund, Sweden Amedeo Avogadro University of Eastern Piedmont, Novara, Italy. 7. Department of Podiatry, Eastern Health, Melbourne, Victoria 3156, Australia.
Abstract
BACKGROUND: Adults with end-stage renal disease are at increased risk of foot ulceration and lower extremity amputation. However, the central determinants of lower limb injury and loss are incompletely understood. METHODS: We conducted a systematic review of non-randomized studies that quantified the major risk factors for foot ulceration and amputation in adults treated with dialysis and analysed patient populations in which risks were greatest. Random-effects meta-analysis was used to generate summary estimates. RESULTS: Thirty studies (48 566 participants) were identified. Risk factors for foot ulceration and amputation included previous foot ulceration (odds ratios, OR, 17.56 and 70.13), peripheral arterial disease (OR, 7.52 and 9.12), diabetes (OR, 3.76 and 7.48), peripheral neuropathy (OR, 3.24 and 3.36) and coronary artery disease (OR, 3.92 and 2.49). Participants with foot ulceration or amputation had experienced a longer duration of diabetes (mean difference, MD, 4.04 and 6.07 years) and had lower serum albumin levels (MD, -0.23 and -0.13 g/dL). Risk factors for foot ulceration also included retinopathy (OR, 3.03), previous amputation (OR, 15.50) and higher serum phosphorus levels (MD, 0.40 mg/dL), while risk factors for amputation also included male sex (OR, 1.50), current smoking (OR, 2.26) and higher glycated haemoglobin levels (MD, 0.75%). CONCLUSIONS: Dialysis patients who have markedly higher risks of ulceration or amputation include those with previous foot ulceration or amputation, peripheral neuropathy, diabetes or macrovascular disease. The temporal relationship between these risk factors and the development of foot ulceration and/or limb loss is uncertain and requires further study. Stable estimates of the key risk factors for ulceration and amputation can inform the design of future trials investigating clinical interventions to reduce the burden of lower limb disease in the dialysis population.
BACKGROUND: Adults with end-stage renal disease are at increased risk of foot ulceration and lower extremity amputation. However, the central determinants of lower limb injury and loss are incompletely understood. METHODS: We conducted a systematic review of non-randomized studies that quantified the major risk factors for foot ulceration and amputation in adults treated with dialysis and analysed patient populations in which risks were greatest. Random-effects meta-analysis was used to generate summary estimates. RESULTS: Thirty studies (48 566 participants) were identified. Risk factors for foot ulceration and amputation included previous foot ulceration (odds ratios, OR, 17.56 and 70.13), peripheral arterial disease (OR, 7.52 and 9.12), diabetes (OR, 3.76 and 7.48), peripheral neuropathy (OR, 3.24 and 3.36) and coronary artery disease (OR, 3.92 and 2.49). Participants with foot ulceration or amputation had experienced a longer duration of diabetes (mean difference, MD, 4.04 and 6.07 years) and had lower serum albumin levels (MD, -0.23 and -0.13 g/dL). Risk factors for foot ulceration also included retinopathy (OR, 3.03), previous amputation (OR, 15.50) and higher serum phosphorus levels (MD, 0.40 mg/dL), while risk factors for amputation also included male sex (OR, 1.50), current smoking (OR, 2.26) and higher glycated haemoglobin levels (MD, 0.75%). CONCLUSIONS: Dialysis patients who have markedly higher risks of ulceration or amputation include those with previous foot ulceration or amputation, peripheral neuropathy, diabetes or macrovascular disease. The temporal relationship between these risk factors and the development of foot ulceration and/or limb loss is uncertain and requires further study. Stable estimates of the key risk factors for ulceration and amputation can inform the design of future trials investigating clinical interventions to reduce the burden of lower limb disease in the dialysis population.
Authors: Ritika Prasad; Thejas Kamath; Charles Ginsberg; O Alison Potok; Joachim H Ix; Pranav S Garimella; Dena E Rifkin Journal: Hemodial Int Date: 2019-02-08 Impact factor: 1.812
Authors: Douglas Franz; Yuanchao Zheng; Nicholas J Leeper; Venita Chandra; Maria Montez-Rath; Tara I Chang Journal: JAMA Intern Med Date: 2018-08-01 Impact factor: 21.873
Authors: Michelle R Kaminski; Anita Raspovic; Lawrence P McMahon; Bircan Erbas; Karl B Landorf Journal: J Foot Ankle Res Date: 2015-09-18 Impact factor: 2.303
Authors: Andreja Marn Pernat; Vanja Peršič; Len Usvyat; Lynn Saunders; John Rogus; Franklin W Maddux; Eduardo Lacson; Peter Kotanko Journal: BMJ Open Diabetes Res Care Date: 2016-03-03
Authors: Michelle R Kaminski; Anita Raspovic; Lawrence P McMahon; Katrina A Lambert; Bircan Erbas; Peter F Mount; Peter G Kerr; Karl B Landorf Journal: BMC Nephrol Date: 2017-09-08 Impact factor: 2.388